Patients with schizophrenia who receive a long-acting injectable (LAI) formulation as the first anti...

Most individuals experiencing a first episode of psychosis who participated in the RAISE (Recovery A...

As the number of hospitalizations for opioid misuse continues to grow, so too have questions of whet...

The FDA on Tuesday issued a warning that the antipsychotic olanzapine may cause a rare but serious s...

APA this week released the Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psy...

The Food and Drug Administration (FDA) on Friday approved Nuplazid (pimavanserin) tablets, the first...